Evidence map›Paper›PMID 33755685›Full record

ArticlePloS one2021

Community acceptability to antimalarial mass drug administrations in Magude district, Southern Mozambique: A mixed methods study.

Beatriz Galatas, Hoticha Nhantumbo, Rodolfo Soares, Helder Djive, Ilda Murato, Wilson Simone, Eusebio Macete, N Regina Rabinovich, Pedro Alonso, Baltazar Candrinho and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Mass Drug Administration: Contextual Factor Considerations.The American journal of tropical medicine and hygiene · 2024
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Beatriz GalatasCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.ORCID 0000-0002-9546-6385
Hoticha NhantumboCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Rodolfo SoaresCenter for International Studies (CEI-IUL), Lisbon, Portugal.
Helder DjiveCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Ilda MuratoCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Wilson SimoneCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Eusebio MaceteCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
N Regina RabinovichISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Pedro AlonsoCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Baltazar CandrinhoNational Malaria Control Programme (NMCP), Ministry of Health, Maputo, Mozambique.
Francisco SaúteCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Pedro AideCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Khátia MunguambeCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Manhiça Health Research Centre · MZEduardo Mondlane University · MZHarvard University · USIscte – Instituto Universitário de Lisboa · PTMinistry of Health · MZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to capture the acceptability prior to, during and after the implementation of the first year of MDA rounds conducted under the Magude project, a malaria elimination project in southern Mozambique.

methodsThis was a mixed-methods study, consisting of focus group discussions (FGDs) prior to the implementation of MDA rounds (September 2015), non-participant observations (NPOs) conducted during the MDA rounds (November 2015 -beginning of February 2016), and semi-structured interviews (SSIs) after the second round (end of February 2016). Community leaders, women in reproductive age, general members of the community, traditional healers and health professionals were recruited to capture the opinions of all representing key members of the community. A generic outline of nodes and codes was designed to analyze FGDs and SSI separately. Qualitative and quantitative NPO information was analyzed following a content analysis approach.

findings222 participants took part in the FGDs (n = 154), and SSIs (n = 68); and 318 household visits during the MDA underwent NPOs. The community engagement campaign emerged throughout the study stages as a crucial factor for the acceptability of MDAs. Acceptability was also fostered by the community's general will to cooperate in any government-led activity that would reduce malaria burden, the appropriate behavior and knowledge of field workers, or the fact that the intervention was available free of charge to all. Absenteeism of heads of households was identified as the main barrier for the success of the campaign. The most commonly reported factors that negatively affected acceptability were the fear of adverse events, rumors of deaths, being unable to drink alcohol while taking DHAp, or the fear to take DHAp while in anti-retroviral treatment. Pregnancy testing and malaria testing were generally well accepted by the community.

conclusionMagude's community generally accepted the first and second antimalarial MDA rounds, and the procedures associated to the intervention. Future implementation of antimalarial MDAs in southern Mozambique should focus on locally adapted strategies that engage the community to minimize absenteeism and refusals to the intervention.

Indexed as

AdultAntimalarialsCommunity ParticipationFemaleFocus GroupsHealth PersonnelHumansInfection ControlInterviews as TopicKnowledgeMalariaMaleMass Drug AdministrationMozambiquePatient Acceptance of Health CareAntimalarials

Identifiers

PMID33755685
PMCPMC7987150
OpenAlexW3139469704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.